Clinical trial
A Phase I Study Of Tirapazamine/Cisplatin/Etoposide And Concurrent Thoracic Radiotherapy For Limited Stage Small Cell Lung Cancer
NCT00006487 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study Of Tirapazamine/Cisplatin/Etoposide And Concurrent Thoracic Radiotherapy For Limited Stage Small Cell Lung Cancer
- Lead sponsor
- SWOG Cancer Research Network
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 31, 2000
- Completion date
- July 31, 2004
- Enrollment
- 30 (actual)
- Sites
- 87
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer